Tag: NCDC

  • NCDC reports 214 Lassa fever, 39 deaths in 2025

    NCDC reports 214 Lassa fever, 39 deaths in 2025

    The Nigeria Centre for Disease Control (NCDC) has reported 214 confirmed cases of Lassa fever and 39 deaths in the country this year.

    In its latest Lassa fever report yesterday, the NCDC said there were 71 new cases of the disease from January 13 to January 19. States where these cases were reported include Ondo, Edo, Bauchi, Taraba, Plateau, Ebonyi, Gombe, Nasarawa, Delta and Kogi.

    “Cumulatively in week 3, 2025, 39 deaths have been reported with a case fatality rate (CFR) of 18.2% which is lower than the CFR for the same period in 2024 (20.4%),” the report reads.

    “In total for 2025, 10 states have recorded at least one confirmed case across 43 local government areas.

    Read Also: CJN urged to deploy technology to address delay in justice delivery

    “Seventy-seven (77%) of all confirmed Lassa fever cases were reported from these three states (Ondo, Edo and Bauchi) while 23% were reported from seven states with confirmed Lassa fever cases.

    “Of the 77% confirmed cases, Ondo reported 38%, Edo 22%, and Bauchi 17%.

    “The predominant age group affected is 21-30 years (Range: 3 to 94 years, Median Age: 30 years). The male-to-female ratio for confirmed cases is 1:0.8.

    “The number of suspected cases increased compared to that reported for the same period in 2024.

    “National Lassa fever multi-partner, multi-sectoral Incident Management System (IMS) activated to coordinate the response activities at all levels.”

  • NCDC reports 214 Lassa fever, 39 deaths in one month

    NCDC reports 214 Lassa fever, 39 deaths in one month

    The Nigeria Centre for Disease Control (NCDC) has reported 214 confirmed cases of Lassa fever and 39 deaths in the country this year. 

    In its latest Lassa fever report on Friday, the NCDC said there were 71 new cases of the disease from January 13 to January 19, States where these cases were reported include Ondo, Edo, Bauchi, Taraba, Plateau, Ebonyi, Gombe, Nasarawa, Delta, and Kogi.

    “Cumulatively in week 3, 2025, 39 deaths have been reported with a case fatality rate (CFR) of 18.2% which is lower than the CFR for the same period in 2024 (20.4%),” the report reads.

    “In total for 2025, 10 States have recorded at least one confirmed case across 43 Local Government Areas.

    “Seventy-seven (77%) of all confirmed Lassa fever cases were reported from these three states (Ondo, Edo, and Bauchi) while 23% were reported from 7 states with confirmed Lassa fever cases.

    “Of the 77% confirmed cases, Ondo reported 38%, Edo 22%, and Bauchi 17%.

    Read Also: Lassa fever: NCDC, experts advocate hygiene, early treatment

    “The predominant age group affected is 21-30 years (Range: 3 to 94 years, Median Age: 30 years). The male-to-female ratio for confirmed cases is 1:0.8.

    “The number of suspected cases increased compared to that reported for the same period in 2024.

    “National Lassa fever multi-partner, multi-sectoral Incident Management System (IMS) activated to coordinate the response activities at all levels.”

  • China virus: NCDC reactivates COVID-19 protocols

    China virus: NCDC reactivates COVID-19 protocols

    • Screening of incoming passengers at borders begins

    • ‘No cause for alarm yet’

    The Nigeria Centre for Disease Control (NCDC) declared yesterday that Nigeria is not at risk yet of the Human Metapneumovirus (HMPV) infection.

    In China, thousands of people, especially children,  had been hospitalised due to the infection.

    The centre, apart from its advisory, also introduced COVID-19-like protocols at the airports and borders.

    It listed the measures taken as comprehensive situation analysis at Points of Entry (PoEs); development of an HMPV Entry Implementation Protocol as approved by the Health Minister Prof. Ali Pate and the identification of quarantine facilities for managing suspected or confirmed cases.

    NCDC Director-General (DG) Jide Idris said that following the dynamic risk assessment, the agency, in collaboration with others, is strengthening its preparedness at the PoEs, among other steps, to mitigate the potential transmission of HMPV through international travel.

    “The key actions taken, he said, include a comprehensive situation analysis at PoEs, the development of an HMPV Entry Implementation Protocol approved by the Minister of Health and the identification of quarantine facilities for managing suspected or confirmed cases.”

    He also said Infection Prevention and Control (IPC) materials and Information, Education, and Communication (IEC) resources are being deployed to frontline staff and travelers.

    Idris added that surveillance has been enhanced with the National Influenza Sentinel Surveillance (NISS) sites monitoring Influenza-like Illness (ILI) and Severe Acute Respiratory Infections (SARI), now including testing for HMPV.

    In addition to laboratories in states with international airports being equipped to facilitate the testing, the Director General said hospitals nationwide have received advisories on IPC practices, while healthcare workers are being trained for case management preparedness.

    He also spoke about stockpiles of personal protective equipment, laboratory reagents and essential supplies for deployment.

    Through risk communication and community engagement, Idris said NCDC has continued to ensure clear public messaging, dispelling misinformation, and encouraging appropriate health-seeking behavior, underscoring its commitment to proactive health security.

    Read Also; Tinubu right to ignore IMF, World Bank, says Kalu

    In the health advisory, he emphasized that HMPV spreads through respiratory droplets, close contact, and touching contaminated surfaces, all of which should be avoided.

    Idris noted that overcrowding and poor ventilation, particularly in settings like Internally Displaced Persons (IDP) camps or correctional facilities, significantly increase the risk of transmission.

    To reduce the risk of infection, he urged the members of the public to wash hands frequently with soap and water, cover their mouth and nose when coughing or sneezing, and wear a mask if symptomatic.

    He also advised that crowded spaces should be avoided, maintain distance from sick individuals, disinfect frequently touched surfaces, and self-isolate if unwell while seeking prompt medical care.

    Healthcare workers were also urged to enforce infection prevention measures, use PPE, enhance surveillance, report unusual infection spikes, and educate patients on preventive steps and emergency care.

    Young children, older adults, and immune compromised individuals were also urged to seek immediate medical attention if symptoms worsen.

    The NCDC assurance came on a day that a one-time  Chief Scientist of the World Health Organisation (WHO), Dr. Soumya Swarminathan, dismissed the virus as nothing to panic about.

    He, however, urged people to take normal precautions that are taken for symptoms of cold, including mask wearing and constant washing of hands. 

    HMPV is a respiratory virus that can cause illnesses ranging from mild cold-like symptoms to severe respiratory infections, particularly in young children, older adults, and individuals with weaker immune systems.

    Idris assured that, the agency, in collaboration with the Federal Ministry of Health and Social Welfare, is closely monitoring global developments.

    Idris said: “On January 6, 2025, NCDC, in collaboration with the Federal Ministry of Health and partners such as the World Health Organization (WHO), the United States Centers for Disease Control and Prevention (USCDC), and the United Kingdom Health Security Agency (UKHSA), conducted a dynamic risk assessment for HMPV.

    “The assessment classified the risk of HMPV for Nigeria as moderate. This evaluation will inform and guide preparedness efforts, decision-making, and response strategies to mitigate potential impacts.”

    The DG, however, denied reports that the World Health Organisation (WHO) has declared the virus a Public Health Emergency of International Concern (PHEIC).

    Notwithstanding, he said the agency is proactive about the issue, adding: “It is important to note that the rumor circulating about the WHO declaring HMPV a PHEIC is false and should be disregarded.

    “The WHO has not made such a declaration. Recent reports indicate a significant rise in HMPV cases in China, as well as increased respiratory infections linked to HMPV in countries such as the UK, France, and Germany, particularly during the winter season.

    “The UKHSA has highlighted a notable rise in hospital admissions due to HMPV-related complications, especially among children under five and older adults in care homes.

    “This trend emphasizes the need for heightened preparedness and vigilance.”

    Speaking about the situation in Nigeria, Idris noted that Nigeria operates a National Influenza Sentinel Surveillance (NISS) system, comprising sentinel sites distributed across the six geopolitical zones of the country.

    He said the sites, which include tertiary and secondary health facilities, monitor Influenza-like Illness (ILI) and Severe Acute Respiratory Infections (SARI).

    Idris said: “As of January 6 (yesterday), data from this surveillance system does not indicate any unusual increase in respiratory infections, including those caused by HMPV.

    “However, given the global trends in HMPV cases, NCDC is proactively implementing measures to strengthen the country’s preparedness and response capacity.

    “The agency is closely monitoring the situation and has implemented the following actions to ensure public health safety.”

    The Director of Public Health at the Federal Ministry of Health and Social Welfare, Chukwuma Anyaike, told The Nation that there was no cause for alarm, as the Ministry, in collaboration with NCDC and other critical stakeholders, is fully prepared for health emergencies.

    He said the nation’s laboratories have been strengthened, and surveillance and monitoring have been intensified at all entry ports across the country.

    Emphasizing that the government fully understands the consequences of complacency, he said: “The government is reinforcing its health security measures at all entry points to ensure robust surveillance and preparedness against potential health, threats.

    “A multi-agency approach, involving the Port Health Services, the NCDC and the Department of Public Health, to monitor and screen every individual entering the country has been adopted.

    “What we need to do is enhance surveillance by establishing a strong mechanism at all ports of entry, including international airports, land borders, and seaports.

    “Thermal cameras are already operational, and every traveler is screened for symptoms such as fever, runny nose, or cold. This is part of an ongoing effort to ensure prompt detection and response.”

    Anyaike also emphasised that awareness campaigns would be prioritised to educate citizens on the importance of personal hygiene and preventive practices.

    “Awareness materials will be disseminated shortly, encouraging people to step up hygiene practices, such as frequent hand washing and adhering to respiratory etiquette.

    “To bolster our preparedness, laboratories have been strengthened to ensure swift and accurate testing of any samples, should the need arise. Health workers in hospitals have also been briefed to scrutinise cases closely and flag any potential concerns.”

    Reassuring the public, the director maintained that there was no cause for alarm at this time.

    He added: “This is not an emergency situation, and we have no confirmed cases in the country.

    “However, we are taking proactive measures to ensure that our systems remain vigilant and ready. Border services are on high alert as the government continues to prioritize health security as a critical agenda.”

  • New coronavirus strain: NCDC alerts states, public

    New coronavirus strain: NCDC alerts states, public

    • Agency advises Nigerians to take precautionary measures

    The Nigeria Centre for Disease Control and Prevention (NCDC) has urged state governments across the country to strengthen public health systems in response to the emergence of a new strain of the coronavirus in some parts of the world.

    No evidence of the new strain has been found in Nigeria, according to a statement at the weekend by the Ministry of Health and Social Welfare.

    But the NCDC explained that while the JN.1 variant, classified as a Variant of Interest (VOI), has been reported in Nigeria since January, the XEC sub-variant, a descendant of JN.1, has not been detected in the country. 

    In a public health advisory yesterday, the agency stressed the importance of ensuring that public health infrastructure remained responsive and resilient to address evolving health concerns effectively. 

    It advised states to allocate resources to support laboratories and healthcare facilities, improve surveillance and diagnostic capabilities, and ensure that treatment centres were fully prepared.

    Besides providing support, the NCDC urged the state governments to launch public health campaigns to educate communities on preventive measures and the importance of seeking prompt medical attention. 

    The agency’s advisory followed concerns raised by reports of the SARS-CoV-2 XEC sub-variant, a descendant of the Omicron lineage, which has been detected in several countries, including Australia.

    In its statement on Saturday, the Federal Ministry of Health and Social Welfare had assured Nigerians that there was no evidence of this variant in the country and urged the public to remain calm while adopting necessary preventive measures. 

    But in its statement yesterday, the NCDC highlighted the ongoing evolution of the virus and reaffirmed its commitment to monitoring and analysing local and international surveillance data to guide public health responses.

    The agency said it had continuously upgraded its emergency preparedness and response strategies, including surveillance, detection, stockpiling, and training, to ensure a swift and effective response.

    A dynamic risk and readiness assessment is also being conducted to develop actionable plans, the centre said.

    The NCDC advised all health facilities – public and private – to increase COVID-19 testing among suspected cases and to send all positive samples to its laboratories or other accredited public health laboratories for genomic sequencing.

    The agency also urged citizens to share only verified information to prevent unnecessary panic or anxiety. 

    It described COVID-19 as a significant risk, particularly for the elderly, individuals with chronic illnesses, cancer patients, organ transplant recipients, and those with weakened immune systems.

    The NCDC urged the public to adhere to basic safety measures, including maintaining good personal hygiene, washing hands regularly, using hand sanitisers, and wearing masks in high-risk situations.

    It also encouraged physical distancing, proper ventilation, and prompt medical attention for symptoms such as fever, cough, and difficulty breathing. 

    The NCDC urged healthcare workers to test patients presenting with respiratory or febrile symptoms and to promptly submit SARS-CoV-2 positive samples for sequencing to support national monitoring efforts.

    Read Also: NCDC warns against likely Lassa fever, meningitis outbreak

    The agency emphasised the importance of hand hygiene, the use of personal protective equipment, and adherence to infection prevention and control measures in healthcare settings. 

    It assured the public that it was closely monitoring the global situation and would continue to provide evidence-based updates on any developments related to SARS-CoV-2 that may pose public health risks.

    The NCDC explained that, globally, the XEC variant has been identified in 43 countries across Europe, Asia, North America, and Africa, with Botswana being the most recent African country to report its presence.

    Although the XEC sub-variant has shown higher transmissibility, compared to other variants, there is no evidence of increased severity.

    The NCDC reiterated that the JN.1 and XEC sub-variants remain under monitoring and do not currently pose significant risks. 

    The agency urged Nigerians to remain vigilant and proactive in protecting themselves and their communities, emphasising the importance of full vaccination and booster doses where applicable.

  • NCDC warns against likely Lassa fever, meningitis outbreak

    NCDC warns against likely Lassa fever, meningitis outbreak

    The Nigeria Centre for Disease Control and Prevention (NCDC) has urged Nigerians to increase their personal and environmental hygiene to prevent a likely outbreak of Cerebrospinal Meningitis (CSM) and Lassa fever in the upcoming dry season.

    Lassa fever is an acute viral hemorrhagic fever (VHF) caused by the Lassa virus while meningitis occurs when there is an acute inflammation of the covering of the brain and the spinal cord.

    NCDC’s Director General Jide Idris said the centre’s alert on Lassa fever and meningitis was meant to prevent avoidable loss of lives that would impact individuals, families, and the nation.

    Addressing a public health briefing yesterday in Abuja, the director general highlighted the necessity of early action, given the number of cases both diseases had recorded this year.

    Idris said the NCDC remained committed to comprehensive efforts at reducing the spread and impact of infections across Nigeria. Commenting on Lassa fever, the director general said the Federal Government, through its Ministry of Health and Social Welfare and the NCDC, leads efforts to prevent, detect, and respond to cases of Lassa fever across the country.

    Read Also: Enough is enough

    He said Nigeria had continued to see a steady increase in the number of states reporting Lassa fever cases, due, in part, to improved surveillance, better community awareness, environmental degradation from climate change, and other harmful human activities.

    “In 2022, Nigeria reported 1,067 confirmed cases across 27 states and 112 local government areas.

    “In 2023, 28 states and 114 local government areas reported confirmed cases, with 9,155 suspected cases, 1,270 confirmed cases, and 227 deaths.

    “As of October 13, 2024, 8,569 suspected cases, 1,035 confirmed cases, and 174 deaths have been reported across 28 states and 129 local government areas.

    “The disease is also associated with significant loss of livelihood in the communities it ravages,” he said.

    On meningitis, which is an epidemic-prone disease with cases reported all year round in Nigeria, Idris explained that weather conditions, like the dry season that comes with dust, winds, cold nights, and frequent upper respiratory tract infections, increase the risk of infection, especially with crowding and poor ventilation.

    He said: “The highest burden of CSM in Nigeria occurs in the ‘Meningitis Belt’, which includes all 19 states in the Northern region, the Federal Capital Territory (FCT), and some southern states, such as Bayelsa, Cross River, Delta, Ekiti, Ogun, Ondo, Osun.

    “In 2023/2024, Nigeria recorded 4,915 suspected and 380 confirmed cases with 361 deaths across 174 local government areas in 24 states, including the FCT.

    “A total of 2,281,750 doses of Men 5CV- ACWYX have been deployed to Bauchi, Gombe, Jigawa and Yobe covering 134 wards in the 13 local government areas.

    “The campaign targeted individuals aged 1-29 years, comprising 70 per cent of the population.

    “Despite significant progress in surveillance, diagnostic capacity, and vaccination over the last few years, CSM remains a priority disease and ever-present public health threat in Nigeria with annual outbreaks in high-burden states that present a challenge for people, health systems, economies, and communities.”

  • NCDC raises the alarm over Marburg virus outbreak

    NCDC raises the alarm over Marburg virus outbreak

    • Agency battles cholera surge

    The Nigeria Centre for Disease Control and Prevention (NCDC) has issued a public alert regarding the potential risk of a Marburg virus outbreak in Nigeria.

    Although no cases of the deadly virus have been reported within the country, NCDC Director Genera l(DG), Jide Idris, disclosed that the agency is closely monitoring the situation in Rwanda, where as of October 15, 2024, 62 cases and 15 fatalities have been confirmed.

    According to the World Health Organization (WHO), Marburg virus disease (MVD), formerly known as Marburg hemorrhagic fever, is a severe and often fatal illness in humans, transmitted from fruit bats to people and spreads through human-to-human contact.

    The incubation period ranges from 2 to 21 days, with symptoms beginning abruptly, including high fever, severe headache, and extreme fatigue.

    Muscle pain, watery diarrhea, abdominal cramps, nausea, and vomiting typically follow on the third day.

    Read Also: Outrage over death of resident chased into canal by Lagos Police

    A non-itchy rash may appear between 2 to 7 days after symptoms start. In fatal cases, death usually occurs between 8 and 9 days after onset, often due to severe blood loss and shock.

    Idris, while giving an update on the ongoing response to infectious disease outbreaks and other events of public health importance in Nigeria and globally in Abuja on Thursday, also revealed that as of October 13, 2024, Nigeria has recorded 378 deaths from 14,237 cases of cholera across 35 States and the Federal Capital Territory (FCT), the Nigeria’s Centre for Disease Control (NCDC) has said.

    With the outbreak affecting 339 Local Government Areas (LGAs), with children under five being the most vulnerable, the country’s case-fatality ratio remains at 2.7 percent, he said.

    Also, within the same period, he stated that Nigeria has reported 102 confirmed cases across 26 states and the FCT, from 1,339 suspected cases, adding that while no deaths have been recorded, the steady rise in cases highlights the need for continued vigilance.

    According to him, since the beginning of 2024, Nigeria has also recorded 1,018 confirmed cases of Lassa fever and 172 deaths, with the majority of cases reported from Ondo, Edo, and Bauchi states.

    While the peak of the Lassa fever outbreak was declared over in April, sporadic cases continue to be reported, with 37 new cases and four deaths recorded in the past month alone, he said.

    Furthermore, on Cerebrospinal Meningitis (CSM), the DG said it is a seasonal threat that peaks between January and April, noting that while projections for the upcoming CSM season suggest a moderate number of cases, the NCDC is not taking any chances.

    He, however, assured the public that the Agency has been proactive in its emergency preparedness and response while offering technical and material support wherever a disease outbreak is recorded.

    On the Marburg virus, he said the NCDC cannot afford to take chances with the infectious disease, saying, “The virus, which is highly infectious and similar to Ebola viral disease, following our expert risk assessment conducted, adjudged there is a potential for localized transmission particularly in among populations with high presence of bats and where bats are being used as delicacies if the virus is imported into Nigeria, due to the volume of travel between the two countries.

    “While there is no specific treatment or vaccine for Marburg, the NCDC is prepared to respond.

    “Working with our stakeholders across ministries, departments and agencies of government, we have activated health declaration forms for incoming passengers, especially from affected regions and are ready to isolate suspected cases immediately upon detection.

    “Additionally, we have identified isolation centers and commenced the process of stockpiling the necessary medical supplies to handle potential cases.

    He, however, urged the public to be conscious of their hygiene and how they interact with foreigners, saying, “We urge all Nigerians to remain vigilant, particularly those travelling to regions with reported Marburg cases.

    “Avoid contact with wild animals, especially fruit bats, and seek medical attention immediately if symptoms such as high fever, severe headache, or unexplained bleeding occur.

    “The preventive measures adopted during the Ebola outbreak in Nigeria, such as regular proper hand washing with soap and water under running water or use of alcohol-based hand sanitizer is applicable for the prevention of Marburg viral disease”

  • NCDC alerts Nigerians to Marburg virus outbreak

    NCDC alerts Nigerians to Marburg virus outbreak

    The Nigeria Centre for Disease Control and Prevention (NCDC) has issued a public alert regarding the potential risk of a Marburg virus outbreak in Nigeria. 

    Although no cases of the deadly virus have been reported within the country, NCDC Director General(DG), Jide Idris, disclosed that the agency is closely monitoring the situation in Rwanda, where as of October 15, 2024, 62 cases and 15 fatalities have been confirmed.

    Idris, while giving an update on the ongoing response to infectious disease outbreaks and other events of public health importance in Nigeria and globally in Abuja on Thursday, also revealed that as of October 13, 2024, Nigeria has recorded 378 deaths from 14,237 cases of cholera across 35 States and the Federal Capital Territory (FCT), the Nigeria’s Centre for Disease Control (NCDC) has said.

    With the outbreak affecting 339 Local Government Areas (LGAs), with children under five being the most vulnerable, the country’s case-fatality ratio remains at 2.7 percent, he said.

    Also, within the same period, he stated that Nigeria has reported 102 confirmed cases across 26 states and the FCT, from 1,339 suspected cases, adding that while no deaths have been recorded, the steady rise in cases highlights the need for continued vigilance, said.

    According to him, since the beginning of 2024, Nigeria has also recorded 1,018 confirmed cases of Lassa fever and 172 deaths, with the majority of cases reported from Ondo, Edo, and Bauchi states. 

    While the peak of the Lassa fever outbreak was declared over in April, sporadic cases continue to be reported, with 37 new cases and four deaths recorded in the past month alone, he said. 

    Furthermore, on Cerebrospinal Meningitis (CSM), the DG said it is a seasonal threat that peaks between January and April, noting that while projections for the upcoming CSM season suggest a moderate number of cases, the NCDC is not taking any chances. 

    He, however, assured the public that the Agency has been proactive in its emergency preparedness and response while offering technical and material support wherever a disease outbreak is recorded.

    On the Marburg virus, he said the NCDC can not afford to take chances with the infectious disease, saying, “The virus, which is highly infectious and similar to Ebola viral disease, following our expert risk assessment conducted, adjudged there is a potential for localized transmission particularly in among populations with high presence of bats and where bats are being used as delicacies if the virus is imported into Nigeria, due to the volume of travel between the two countries.

    “While there is no specific treatment or vaccine for Marburg, the NCDC is prepared to respond. 

    “Working with our stakeholders across ministries departments and agencies of government, we have activated health declaration forms for incoming passengers, especially from affected regions and are ready to isolate suspected cases immediately upon detection. 

    “Additionally, we have identified isolation centers and commenced the process of stockpiling the necessary medical supplies to handle potential cases.

    He, however, urged the public to be conscious of their hygiene and how they interact with foreigners, saying, “We urge all Nigerians to remain vigilant, particularly those travelling to regions with reported Marburg cases. 

    “Avoid contact with wild animals, especially fruit bats, and seek medical attention immediately if symptoms such as high fever, severe headache, or unexplained bleeding occur. 

    “The preventive measures adopted during the Ebola outbreak in Nigeria, such as regular proper hand washing with soap and water under running water or use of alcohol-based hand sanitizer is applicable for the prevention of Marburg viral disease”

    On cholera, he said Nigeria has witnessed two significant waves of cholera, with the most recent surge, reported during the week of September 29 (Epi Week 39) being attributed to the heavy rains, adding that the number of suspected cholera cases and deaths in 2024 has more than doubled when compared to this time last year. 

    He said the high number of cholera cases reflected the severity of the outbreak and reinforced the need for continuous vigilance and action. 

    According to him, the recent floods in the northern states such as Borno, Adamawa, Jigawa, Yobe, and Kano have exacerbated the spread of cholera, making these states the current epicentres of the outbreak.

    Speaking on the changing pattern of cholera disease spread, the DG said, “Earlier in the year, the cholera cases were concentrated in southern states but as the rains began, we have seen a shift, with northern states now accounting for a significant portion of cases”. 

    Idris, however, said the agency has deployed rapid response teams to the affected areas, coordinating with local authorities and providing critical supplies like medicines and water purification tablets. 

    In collaboration with the National Primary Health Care Development Agency (NPHCDA), the DG said the NCDC has also supported reactive cholera vaccinations in internally displaced persons (IDP) camps, which has helped reduce cases.

    The NCDC urges Nigerians to maintain good hygiene, including regular hand washing and seeking immediate medical attention if cholera symptoms arise. 

    With continued efforts to improve surveillance and strengthen water sanitation, the country aims to control and ultimately eliminate cholera as a public health threat.

    On Mpox, he said the agency has deployed a response mechanism focusing on stakeholder engagement, surveillance and diagnostic capacity, community engagement, and vaccination campaign, to address the situation 

    On Lassa fever, he said to mitigate the risk, NCDC is strengthening its preparedness for the upcoming Lassa fever season. “We have reviewed our response to the previous outbreak, identifying lessons learned to enhance future interventions. 

    Read Also: Lassa Fever cases surge in Ondo, Edo — NCDC

    “Findings have identified kidney failure as a major cause of death from Lassa fever. In addressing this, training of healthcare workers at both the state and local levels is ongoing to ensure rapid case detection, accurate reporting, and effective management. 

    “We have procured and installed 12 dialysis machines across our treatment centres. Additionally, we are stockpiling essential medical supplies—such as personal protective equipment, medicines, and diagnostic tools—in high-risk states to ensure a swift response should an outbreak occur,” he said.

    The DG also explained while projections for the upcoming CSM season suggest a moderate number of cases, the NCDC is not taking any chances, saying, “Over 400 healthcare workers across nine states have been trained in case management and cerebrospinal fluid collection, which is essential for accurate laboratory diagnosis and effective treatment. 

    “Additionally, we are conducting operational research in collaboration with our partners and convening stakeholders for after-action reviews to ensure that our response strategies are both evidence-based and cost-effective”.

  • Lassa Fever cases surge in Ondo, Edo — NCDC

    Lassa Fever cases surge in Ondo, Edo — NCDC

    The Nigeria Centre for Disease Control and Prevention (NCDC) recorded a rise in Lassa fever cases in week 39 of 2024, with Ondo and Edo states reporting nine new confirmed cases.

    The NCDC stated this on its official website, based on the latest Lassa Fever Situation Report.

    The agency said this marked an increase from four cases reported in previous week, raising the total number of infections and deaths in the year to alarming levels.

    The NCDC revealed that “the country is witnessing a surge in Lassa fever cases, with the total number of infections in 2024 rising to 1,018 across 28 states.

    “As of week 39 (September 23-29), 172 deaths have been reported, reflecting a slight increase in the Case Fatality Rate (CFR) to 16.9 per cent, compared to 16.8 per cent in the same period in 2023.”

    It highlighted that the new confirmed cases were recorded in Ondo and Edo states, two of the three states that account for 68 per cent of all confirmed cases in 2024.

    It noted that “Ondo reported 28 per cent of the cases, followed by Edo with 23 per cent and Bauchi, 17 per cent.”

    The NCDC said that the predominant age group affected by the disease ranged from 31 to 40 years, with an equal number of male and female patients.

    It said that no healthcare workers were affected during the reporting week, a positive sign amid heightened number of cases.

    Read Also: Lassa Fever cases surge in Ondo, Edo — NCDC

    The Nigerian public health agency said that in spite of nationwide efforts to curb spread of the disease, the increasing number of deaths is worrisome.

    It attributed the high CFR to late presentation of cases, poor health-seeking behaviour and inadequate environmental sanitation in high-burden communities.

    It noted that the challenges, coupled with limited access to treatment, were posing significant threats to the country’s ability to reduce fatalities.

    The agency said the National Lassa Fever Technical Working Group (TWG) had continued to coordinate response activities, while alerts were sent through the Nigeria Preparedness and Readiness Alert System (NPRAS) on ongoing efforts.

    The NCDC added that its partners had rolled out various interventions to bolster efforts toward tackling the menace.

    Lassa fever, identified by the World Health Organisation as a pathogen with high potential for severe outbreaks, poses a growing threat as climate change puts an estimated 700 million people at risk.

    Symptoms of the disease include fever, headache, muscle pain, and in severe cases, facial swelling and bleeding, as survivors often suffer from long-term complications, such as deafness.

    Meanwhile, as Nigeria battles the ongoing Lassa fever outbreak, public health experts said concerted efforts are required from both the government and the public to avert further loss of lives.

  • Lassa Fever cases surge in Ondo, Edo — NCDC

    Lassa Fever cases surge in Ondo, Edo — NCDC

    The Nigeria Centre for Disease Control and Prevention (NCDC) recorded a rise in Lassa fever cases in week 39 of 2024, with Ondo and Edo states reporting nine new confirmed cases.

    The NCDC stated this on its official website, based on latest Lassa Fever Situation Report.

    The agency said that this marked an increase from four cases reported in  previous week, raising the total number of infection and deaths in the year to alarming levels.

    The NCDC revealed that “the country is witnessing a surge in Lassa fever cases, with the total number of infections in 2024 rising to 1,018 across 28 states.

    “As of week 39 (September 23-29), 172 deaths have been reported, reflecting a slight increase in the Case Fatality Rate (CFR) to 16.9 per cent, compared to 16.8 per cent in the same period in 2023.”

    It highlighted that the new confirmed cases were recorded in Ondo and Edo states, two of the three states that account for 68 per cent of all confirmed cases in 2024.

    It noted that “Ondo reported 28 per cent of the cases, followed by Edo with 23 per cent and Bauchi, 17 per cent.”

    Read Also: Mpox: NCDC confirms 40 cases as US donates vaccine to Nigeria

    The NCDC said that the predominant age group affected by the disease ranged from 31 to 40 years, with an equal number of male and female patients.

    It said that no healthcare workers were affected during the reporting week, a positive sign amid heightened number of cases.

    The Nigerian public health agency said that in spite of nationwide efforts to curb spread of the disease, the increasing number of deaths is worrisome.

    It attributed the high CFR to late presentation of cases, poor health-seeking behaviour and inadequate environmental sanitation in high-burden communities.

    It noted that the challenges, coupled with limited access to treatment, were posing significant threats to the country’s ability to reduce fatalities.

    The agency said the National Lassa Fever Technical Working Group (TWG) had continued to coordinate response activities, while alerts were sent through the Nigeria Preparedness and Readiness Alert System (NPRAS) on ongoing efforts.

    The NCDC added that its partners had rolled out various interventions to bolster efforts toward tackling the menace. 

    Lassa fever, identified by the World Health Organisation as pathogen with high potential for severe outbreaks, poses growing threat as climate change puts an estimated 700 million people at risk.

    Symptoms of the disease include fever, headache, muscle pain, and in severe cases, facial swelling and bleeding, as survivors often suffer from long-term complications, such as deafness.

    Meanwhile, as Nigeria battles the ongoing Lassa fever outbreak, public health experts said concerted efforts are required from both the government and the public to avert further loss of lives.

    (NAN)

  • Real Pharmaceutical donates drugs to states  with Cholera outbreaks 

    Real Pharmaceutical donates drugs to states  with Cholera outbreaks 

    In response to the rising Cholera outbreaks affecting several states across the country, Reals Pharmaceutical Ltd, a leading pharmaceutical company, has donated hundreds of life-saving drugs to the impacted regions.

    The donation comes at a crucial moment as many states struggle with the health crisis, which has reportedly claimed hundreds of lives and overwhelmed healthcare systems in affected areas.

    Cholera, an acute diarrheal disease caused by consuming contaminated food or water, remains a persistent challenge in Nigeria, especially in regions with poor sanitation and limited access to clean water.

     According to Nigeria Center for Disease Control (NCDC), the 2024 outbreak has been specifically severe, with over 4,809 suspected cases, resulting in 156 deaths that have been recorded across the federation especially, in the most affected areas. 

    The alarming situation underscores the Federal Government’s and international organizations’—including the World Health Organization (WHO)—call for urgent medical supplies, clean water, and improved sanitation to curb the spread of the disease.

    In response, and as part of its Corporate Social Responsibility, Reals Pharmaceutical Ltd stepped in to provide relief by donating its ready-to-drink Oral Rehydration Solution (ORS) known as “Electrorush” to the hardest-hit states.

    According to a statement from the company’s management, arrangements have been finalized to carry out this CSR initiative in Borno and Adamawa States, with plans to donate “Electrorush” to regions where cholera outbreaks continue to threaten public health.

    Read Also: Cholera outbreak: 287,708 people vaccinated in Borno – Commissioner

    This effort aims not only to improve public health in these states but also to aid in the treatment of those affected by the disease and reduce mortality rates. Recently, the company visited Ebonyi State to donate 600 packs of “Electrorush” to the state government, supporting the treatment of patients suffering from the ongoing cholera outbreak. 

    The contribution is part of the company’s wider commitment to easing the impact of cholera in the most affected regions.

     Presenting the drug at the Ebonyi State Ministry of Health in Abakaliki, the Group Managing Director, Ade Popoola, who was represented by Business Manager East, Lucky Uwajei stated that the donation was part of Reals’ Corporate Social Responsibility and will help those affected by the disease.

     “In line with our commitment to supporting public health initiatives, Reals Pharmaceutical Limited is pleased to offer a substantial donation of Electrorush, the first ready-to-drink oral rehydration solution (ORS) in Nigeria.

    “We understand the vital importance of rehydration in the treatment of cholera, particularly in preventing dehydration associated with acute diarrhoea.

    “Electrorush is particularly formulated to provide immediate hydration and assist in recovery during diarrhoea episodes, making it an essential resource in this challenging time.

     “We look forward to collaborating with your office and the director of Pharmaceutical Services to ensure that these donations effectively reach the communities most impacted by the outbreak,” the MD stated. 

    Receiving the donation on behalf of the state government, the Commissioner for Health, Moses Ekuma said Ebonyi state is in a difficult period because of the outbreak of cholera. 

    He  said: “It just came suddenly. Of course, we have been witnessing such in the past but this year it came in a bigger magnitude. 

     “This drink is very important because one problem we have with sachet ORS is that either it is over-diluted or under-diluted and either of those is not good. The quality of water is also not guaranteed.

    “After all, it must cause some problems. But this Electrorush is wonderful because you don’t need any dilution again, you just open and drink.” Electrorush is a scientifically formulated, ready-to-drink Oral Rehydration Solution (ORS) designed to address the limitations of sachet ORS. 

    “By providing a pre-mixed, ready-to-consume solution, Electrorush offers benefits such as immediate rehydration, safety, convenience and effectiveness in cholera treatment. 

    “It’s also pleasantly tasting for Children. Through these donations, Reals Pharmaceutical aims to provide a swift and effective response to the public health crises facing these states.”

    The company noted that it remains committed to partnering with governments and health authorities to ensure access to life-saving rehydration solutions, helping communities combat preventable diseases like Cholera.